Lanzamiento Enero 2027

Ensayo controlado aleatorizado2003Financiación no declarada

Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids

Barbosa DS, Cecchini R, El Kadri MZ, Rodríguez MA, Burini RC, Dichi I

Nutrition (Burbank, Los Angeles County, Calif.) · 126 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2003-10-01 · Nutrition · vol. 19 · número 10 · págs. 837–842
Editorial
Elsevier BV
Citado
182 citas · más que el 95% de estudios similares · 4.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
37 trabajos
Acceso
De pago
Áreas de investigación
Inflammatory Bowel Disease · Fatty Acid Research and Health · Antioxidant Activity and Oxidative Stress
Palabras clave
ulcerative colitis, fish oil, omega-3 fatty acids, oxidative stress, sulfasalazine, chemiluminescence, lipid peroxidation, malondialdehyde, superoxide dismutase, catalase, antioxidant capacity, free radicals, anti-inflammatory therapy, disease activity, erythrocyte sedimentation rate, C-reactive protein, alpha-1-acid glycoprotein
MeSH
colon, humans, colitis, ulcerative, reactive oxygen species, sulfasalazine, fatty acids, omega-3, fish oils, gastrointestinal agents, sigmoidoscopy, blood sedimentation, treatment outcome, drug therapy, combination, cross-over studies, lipid peroxidation, oxidative stress, adult, female, male

6 autores

  • Décio Sabbatini Barbosa🇧🇷Universidade Estadual de Londrina
  • Rúbens Cecchini🇧🇷Universidade Estadual de Londrina
  • Mirian Zebian El Kadri🇧🇷Universidade Estadual de Londrina
  • Maria Aparecida Marchesan Rodrigues🇧🇷Universidade Estadual Paulista (Unesp)
  • Roberto Carlos Burini🇧🇷Universidade Estadual Paulista (Unesp)
  • Isaías Dichi🇧🇷 · autor de correspondenciaUniversidade Estadual de Londrina

Resumen

El texto original del estudio, en el idioma en que se publicó.

Objective

The potential pathogenicity of free radicals may have a pivotal role in ulcerative colitis. Fish oil omega-3 fatty acids exert anti-inflammatory effects on patients with ulcerative colitis (UC), but the precise mechanism of the action of fish oil on oxidative stress is still controversial. The aim of the present work was to verify the blood oxidative stress in patients with UC and determine whether the association of sulfasalazine to fish oil omega-3 fatty acids is more effective than isolated use of sulfasalazine to reduce the oxidative stress.

Methods

Nine patients (seven female and two male; mean age = 40 +/- 11 y) with mild or moderate active UC were studied in a randomized crossover design. In addition to their usual medication (2 g/d of sulfasalazine), they received fish oil omega-3 fatty acids (4.5 g/d) or placebo for 2-mo treatment periods that were separated by 2 mo, when they only received sulfasalazine. Nine healthy individuals served as control subjects to study the oxidative stress status. Disease activity was assessed by laboratory indicators (C-reactive protein, alpha1-acid glycoprotein, alpha1-antitrypsin, erythrocyte sedimentation rate, albumin, hemoglobin, and platelet count), sigmoidoscopy, and histology scores. Analysis of oxidative stress was assessed by plasma chemiluminescence and erythrocyte lipid peroxidation, both induced by tert butyl hydroperoxide (t-BuOOH) and by plasma malondialdehyde. Antioxidant status was assayed by total plasma antioxidant capacity (TRAP) and microsomal lipid peroxidation inhibition (LPI). Superoxide dismutase (SOD) and catalase erythrocyte enzymatic activities were also determined.

Results

No significant changes were observed in any laboratory indicator or in the sigmoidoscopy or histology scores, with the exception of erythrocyte sedimentation rate, which decreased with both treatments. Oxidative stress was demonstrated by significant decreases in TRAP and LPI levels, increased chemiluminescence induced by t-BuOOH, and higher SOD activity in patients with UC. Treatment with fish oil omega-3 fatty acids reverted the chemiluminescence induced by t-BuOOH and LPI to baseline levels but that did not occur when patients received only sulfasalazine. Levels of plasma malondialdehyde, erythrocyte lipid peroxidation, and catalase were not different from those in the control group.

Conclusions

The results indicated that plasma oxidative stress occurs in patients with UC, and there was a significant decrease when the patients used sulfasalazine plus fish oil omega-3 fatty acids. However, there was no improvement in most laboratory indicators, sigmoidoscopy, and histology scores. The results suggested that omega-3 fatty acids may act as free radical scavengers protecting the patients against the overall effect of oxidative stress.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.